Showing results (251-260 of 335) with videos related to
Sort By:
Pageof 34
International Journal of Chronic Obstructive Pulmonary Disease|October 29, 2020
Defining Chronic Mucus Hypersecretion Using the CAT in the SPIROMICS CohortMarni Stott-Miller, Hana Müllerová, Bruce Miller, et al.International Journal of Chronic Obstructive Pulmonary Disease|August 22, 2020
Novel Respiratory Disability Score Predicts COPD Exacerbations and Mortality in the SPIROMICS CohortChristopher B Cooper, Robert Paine, Jeffrey L Curtis, et al.Journal of Occupational and Environmental Medicine|March 28, 2023
Association of Occupational Exposures and Chronic Obstructive Pulmonary Disease MorbidityJennifer S Rous, Peter S J Lees, Kirsten Koehler, et al.American Journal of Respiratory and Critical Care Medicine|August 27, 2016
Age and Small Airway Imaging Abnormalities in Subjects with and without Airflow Obstruction in SPIROMICSCarlos H Martinez, Alejandro A Diaz, Catherine Meldrum, et al.Chest|November 12, 2021
Significance of FEV3/FEV6 in Recognition of Early Airway Disease in Smokers at Risk of Development of COPD: Analysis of the SPIROMICS CohortNathan Yee, Daniela Markovic, Russell G Buhr, et al.Plos One|March 17, 2021
The influence of social support on COPD outcomes mediated by depressionLeonard Turnier, Michelle Eakin, Han Woo, et al.Chest|January 27, 2019
Systemic Markers of Inflammation in Smokers With Symptoms Despite Preserved Spirometry in SPIROMICSSuresh Garudadri, Prescott G Woodruff, MeiLan K Han, et al.Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|October 27, 2020
Plasma Cathelicidin is Independently Associated with Reduced Lung Function in COPD: Analysis of the Subpopulations and Intermediate Outcome Measures in COPD Study CohortRobert M Burkes, Agathe S Ceppe, David J Couper, et al.Respiratory Research|November 21, 2018
Heterogeneous burden of lung disease in smokers with borderline airflow obstructionCheryl S Pirozzi, Tian Gu, Pedro M Quibrera, et al.Journal of Medicinal Chemistry|July 1, 2025
Thioquinazolinones as Antituberculosis Agents Targeting Phosphopantetheinyl TransferaseAmrita Singh, Logan T Zwerneman, Kyle Planck, et al.Pageof 34